Abstract:Background: Apolipoprotein-E ( APOE ) ε4 is a major genetic risk factor for Alzheimer's disease (AD). Current studies, which were mainly based on the clinical diagnosis rather than biomarkers, come to inconsistent conclusions regarding the associations of APOE ε4 homozygotes ( APOE ε4/ε4 ) and cerebrospinal fluid (CSF) biomarkers of AD. In addition, few studies have explored the associations of APOE ε4/ε4 with plasma biomarkers. Therefore, we aimed to investigate the associations of APOE ε4/ε4 with fluid biomarkers in dementia and biomarker-diagnosed AD. Methods: A total of 297 patients were enrolled. They were classified into Alzheimer's continuum, AD, and non-AD, according to CSF biomarkers and/or β amyloid PET results. AD was a subgroup of the AD continuum. Plasma Amyloid β (Aβ) 40, Aβ42, glial fibrillary acidic protein (GFAP), neurofilament light chain (NFL), and phosphorylated tau (P-tau)181 were quantified in 144 of the total population using an ultra-sensitive Simoa technology. We analyzed the associations of APOE ε4/ε4 on CSF and plasma biomarkers in dementia and biomarker diagnosed AD. Results: Based on the biomarker diagnostic criteria, 169 participants were diagnosed with Alzheimer's continuum and 128 individuals with non-AD, and among the former, 120 patients with AD. The APOE ε4/ε4 frequencies were 11.8% (20/169), 14.2% (17/120), and 0.8% (1/128) in Alzheimer's continuum, AD and non-AD, respectively. Only CSF Aβ42 was shown to be decreased in APOE ε4/ε4 carriers than in non-carriers for patients with AD ( p = 0.024). Furthermore, we did not find any associations of APOE ε4 with plasma biomarkers of AD and non-AD. Interestingly, we found that in non-AD patients, APOE ε4 carriers had lower CSF Aβ42 ( p = 0.018) and higher T-tau/Aβ42 ratios ( p < 0.001) and P-tau181/Aβ42 ratios ( p = 0.002) than non-carriers. Conclusion: Our data confirmed that of the three groups (AD continuum, AD, and non-AD), those with AD had the highest frequency of APOE ɛ4/ɛ4 genotypes. The APOE ɛ4/ɛ4 was associated with CSF levels of Aβ42 but not tau for AD and non-AD, suggesting that APOE ɛ4/ɛ4 affected the Aβ metabolism of both. No associations between APOE ε4/ɛ4 and plasma biomarkers of AD and non-AD were found.

Apolipoprotein E Ε4 Modifies the Effect of Possible Anticholinergic Drugs on Incident Dementia: the Shanghai Aging Study

Effects of Apolipoprotein E on Dementia and Aging in the Shanghai Survey of Dementia

Effects of Apolipoprotein E-ε4 and -Ε2 in Amnestic Mild Cognitive Impairment and Dementia in Shanghai: SCOBHI-P

Decreased Function of Delayed Recall in Non-demented Elderly Subjects With Apolipoprotein E ε4 Allele.

Effects of Apolipoprotein E Allele and Age in Alzheimer’s Disease and Mild Cognitive Impairment in a Memory Clinic Cohort in Beijing

Decreased Inter-Hemispheric Functional Connectivity in Cognitively Intact Elderly APOE Ɛ4 Carriers: A Preliminary Study

Correlation Between the APOE Ε4 Genotype, Lifestyle Habits, and Cognitive Deficits in Chinese Adults over 60: a Cross-Sectional Analysis in China

Associations Between APOE Genotype and Cerebral Small-Vessel Disease: a Longitudinal Study

Frequency of the Apolipoprotein E Ε4 Allele in a Memory Clinic Cohort in Beijing: a Naturalistic Descriptive Study.

Synergistic effect between apolipoprotein E ε4 and diabetes mellitus for dementia: result from a population-based study in urban China.

Association of APOE ε4/ε4 with fluid biomarkers in patients from the PUMCH dementia cohort

P4‐142: Contact Factors Differ for Dementia and Amnestic MCI in Chinese Elders: the Pilot SCOBHI Study.

P2‐067: Shanghai Community Brain Health Initiative (scobhi) Pilot Study: Apoe Findings

Interactions between the apolipoprotein E4 gene and modifiable risk factors for cognitive impairment: a nationally representative panel study

The Apolipoprotein E Ε4 Allele-Dependent Relationship Between Serum Lipid Levels and Cognitive Function: A Population-Based Cross-sectional Study

Age-Related Association Between APOE 4 and Cognitive Progression in de novo Parkinson's Disease

Effects of Apolipoprotein E4 Genotype on Cerebro-Cerebellar Connectivity, Brain Atrophy, and Cognition in Patients with Alzheimer's Disease

Short-term Adverse Effects of the Apolipoprotein E Ε4 Allele over Language Function and Executive Function in Healthy Older Adults.

Associations between apolipoprotein E gene polymorphisms and Alzheimer's disease risk in a large Chinese Han population.

Associations Between APOE Polymorphisms and Seven Diseases with Cognitive Impairment Including Alzheimer’s Disease, Frontotemporal Dementia, and Dementia with Lewy Bodies in Southeast China

APOE Ε4 Allele Accelerates Age-Related Multi-Cognitive Decline and White Matter Damage in Non-Demented Elderly.